These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17549641)

  • 1. Arsenic trioxide and neuroblastoma cytotoxicity.
    Pettersson HM; Karlsson J; Pietras A; Øra I; Påhlman S
    J Bioenerg Biomembr; 2007 Feb; 39(1):35-41. PubMed ID: 17549641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y; Yamada H; Nakagawa Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].
    Tajima M
    Nihon Yakurigaku Zasshi; 2005 Jun; 125(6):389-96. PubMed ID: 16079563
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia.
    Karlsson J; Edsjö A; Påhlman S; Pettersson HM
    Mol Cancer Ther; 2005 Jul; 4(7):1128-35. PubMed ID: 16020671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide.
    Litzow MR
    Expert Opin Pharmacother; 2008 Jul; 9(10):1773-85. PubMed ID: 18570609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia.
    Carney DA
    Leuk Lymphoma; 2008 Oct; 49(10):1846-51. PubMed ID: 18949607
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
    Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
    Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
    Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
    Leu L; Mohassel L
    Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-biomodulation with arsenic trioxide in multiple myeloma.
    Gallagher RE
    Leuk Res; 2001 Mar; 25(3):237-9. PubMed ID: 11226520
    [No Abstract]   [Full Text] [Related]  

  • 12. Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies.
    Tallman MS
    Blood Rev; 2001 Sep; 15(3):133-42. PubMed ID: 11735161
    [No Abstract]   [Full Text] [Related]  

  • 13. Overcoming treatment resistance in acute promyelocytic leukemia and beyond.
    Fung TK; So CW
    Oncotarget; 2013 Aug; 4(8):1128-9. PubMed ID: 23934744
    [No Abstract]   [Full Text] [Related]  

  • 14. Arsenic reverses glioblastoma resistance to mTOR-targeted therapies.
    Iwanami A; Cloughesy TF; Cavenee WK; Mischel PS
    Cell Cycle; 2013 May; 12(10):1473-4. PubMed ID: 23624839
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide - An old drug rediscovered.
    Emadi A; Gore SD
    Blood Rev; 2010; 24(4-5):191-9. PubMed ID: 20471733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute promyelocytic leukemia with arsenic trioxide.
    Tamm I; Paternostro G; Zapata JM
    N Engl J Med; 1999 Apr; 340(13):1043; author reply 1044-5. PubMed ID: 10189285
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arsenic trioxide in the treatment of acute promyelocytic leukaemia].
    Ercilla Liceaga M; Andueza Granados K; Fernández González I; Barcia Romero MJ
    Farm Hosp; 2003; 27(2):93-100. PubMed ID: 12717564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide: acute promyelocytic leukemia and beyond.
    Bachleitner-Hofmann T; Kees M; Gisslinger H
    Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arsenic trioxide: impact on the growth and differentiation of cancer cells and possible use in cancer therapy].
    Hoffman E; Mielicki WP
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():817-27. PubMed ID: 24018447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.